Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter protein ABC1

Details for Australian Patent Application No. 2005200171 (hide)

Owner CV Therapeutics, Inc.

Inventors Wade, David; Lawn, Richard M; Garvin, Michael

Agent Freehills

Pub. Number AU-A-2005200171

Parent 777461

Filing date 14 January 2005

Wipo publication date 10 February 2005

International Classifications

C12N 015/52 Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 014/705 Peptides having more than 20 amino acids

A61K 038/00 Medicinal preparations containing peptides

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

3 February 2005 Complete Application Filed

10 February 2005 Application Open to Public Inspection

  Published as AU-A-2005200171

22 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005200172-Benzimidazole derivatives

2005200170-Diagnostics and therapeutics for drusen associated ocular disorders